Daiichi Sankyo Company, Limited (DSNKY) Financials
DSNKY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 25.1 billion | 14.7 billion |
| March 31, 2026 | 25.2 billion | 14.7 billion |
| Dec. 31, 2025 | 24.4 billion | 13.5 billion |
| Sept. 30, 2025 | 24.1 billion | 12.9 billion |
DSNKY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -105.3 million | ? |
| March 31, 2026 | -22.3 million | ? |
| Dec. 31, 2025 | 346.4 million | ? |
| Sept. 30, 2025 | -209.9 million | ? |
DSNKY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 427.6 million |
| March 31, 2026 | 270.5 million |
| Dec. 31, 2025 | 563.0 million |
| Sept. 30, 2025 | 311.5 million |
DSNKY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.9 billion | - | - |
| March 31, 2026 | 2.8 billion | - | - |
| Dec. 31, 2025 | 3.5 billion | - | - |
| Sept. 30, 2025 | 4.0 billion | - | - |
DSNKY Shares Outstanding
DSNKY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 232.0 million | 719.2 million | - | - |
| March 31, 2026 | 185.4 million | 804.8 million | - | - |
| Dec. 31, 2025 | 199.9 million | 793.5 million | - | - |
| Sept. 30, 2025 | 268.6 million | 768.0 million | - | - |
DSNKY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 3.6 billion | 774.3 million |
| March 31, 2026 | 3.8 billion | 1.9 billion |
| Dec. 31, 2025 | 3.6 billion | 768.6 million |
| Sept. 30, 2025 | 3.4 billion | 1.1 billion |
DSNKY
Price: $17.29
52 week price:
Dividend Yield: 2.84%
Payout Ratio Range:
Earnings Per Share: 0.90 USD
P/E Ratio: 21
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 31.6 billion